{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:06:59Z","timestamp":1790348819318,"version":"4.1.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The COVID-19 pandemic caused by SARS-CoV-2 continues to pose a major challenge to global health. Targeting the main protease of the virus (Mpro), which is essential for viral replication and transcription, offers a promising approach for therapeutic intervention. In this study, advanced computational techniques such as molecular docking and molecular dynamics simulations were used to screen a series of antiviral compounds for their potential inhibitory effect on the SARS-CoV-2 Mpro. A comprehensive analysis of compounds from the ChemDiv and PubChem databases was performed. The physicochemical properties, pharmacokinetics, and ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) profiles were evaluated to determine drug similarity and safety. Compound 4896\u2009\u2212\u20094038 proved to be the most promising candidate. It exhibited a favorable balance between molecular weight (491.06) and lipophilicity (logP 3.957), high intestinal absorption (92.119%), and broad tissue distribution (VDss of 0.529), indicating good oral bioavailability and therapeutic potential. Molecular docking studies showed that 4896\u2009\u2212\u20094038 has a strong binding affinity to the active site of Mpro and forms key interactions, such as hydrogen bonds, carbon-hydrogen bonds, pi-sulfur, and multiple van der Waals and pi-pi stacked bonds. The binding energy was comparable to that of the reference drug X77, indicating potential efficacy. Molecular dynamics simulations over 300 ns confirmed the stability of the Mpro\/4896\u2009\u2212\u20094038 complex of protein-ligand. Free energy landscape mapping and MM\/PBSA calculations further substantiated the favorable binding and stability of the complex. Importantly, 4896\u2009\u2212\u20094038 exhibited a comparatively favorable safety profile. In summary, compound 4896\u2009\u2212\u20094038 shows significant potential as a potent SARS-CoV-2 Mpro inhibitor, combining potent inhibitory activity with favorable pharmacokinetic and safety profiles. These results support the further development of 4896\u2009\u2212\u20094038 as a promising therapeutic agent in the fight against COVID-19 that warrants experimental validation and clinical investigation.<\/jats:p>","DOI":"10.1038\/s41598-025-86016-9","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T14:47:29Z","timestamp":1737557249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Identification of promising SARS-CoV-2 main protease inhibitor through molecular docking, dynamics simulation, and ADMET analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Ganesh","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Shekhar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewulsew Kebede","family":"Tiruneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharifa","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Vin\u00edcius","family":"Rolim Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"de Lima Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi E. A.","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas Ivan","family":"Nobre Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,22]]},"reference":[{"key":"86016_CR1","doi-asserted-by":"publisher","first-page":"138996","DOI":"10.1016\/j.scitotenv.2020.138996","volume":"730","author":"T Acter","year":"2020","unstructured":"Acter, T. et al. Evolution of severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) as Coronavirus Disease 2019 (COVID-19) pandemic: A Global Health Emergency. Sci. Total Environ. 730, 138996. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.138996 (2020).","journal-title":"Sci. Total Environ."},{"key":"86016_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/10408363.2020.1783198","volume":"57","author":"M Ciotti","year":"2020","unstructured":"Ciotti, M. et al. The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 57, 365\u2013388. https:\/\/doi.org\/10.1080\/10408363.2020.1783198 (2020).","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"86016_CR3","doi-asserted-by":"publisher","unstructured":"BS, M. & Nambiar, V. COVID-19: an insight into SARS-CoV-2 Pandemic originated at Wuhan City in Hubei Province of China., https:\/\/doi.org\/10.23937\/2474-3658\/1510146","DOI":"10.23937\/2474-3658\/1510146"},{"key":"86016_CR4","doi-asserted-by":"publisher","unstructured":"Laskar, P., Yallapu, M. M. & Chauhan, S. C. Tomorrow never dies: recent advances in diagnosis, treatment, and Prevention modalities against Coronavirus (COVID-19) amid controversies. Diseases 8 https:\/\/doi.org\/10.3390\/diseases8030030 (2020).","DOI":"10.3390\/diseases8030030"},{"key":"86016_CR5","unstructured":"Wambua, D. Human Rights Dimension of a Pandemic: Evaluation of the Effect of Covid 19 on the Right to Education in Kenya. Thesis, University of Nairobi, (2021)."},{"key":"86016_CR6","doi-asserted-by":"publisher","unstructured":"Graham, B. S. Advances in antiviral Vaccine Development. Immunol. Rev. 255 https:\/\/doi.org\/10.1111\/imr.12098 (2013).","DOI":"10.1111\/imr.12098"},{"key":"86016_CR7","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"CC Lai","year":"2020","unstructured":"Lai, C. C., Shih, T. P., Ko, W. C., Tang, H. J. & Hsueh, P. R. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and coronavirus Disease-2019 (COVID-19): the Epidemic and the challenges. Int. J. Antimicrob. Agents. 55, 105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"86016_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","volume":"38","author":"C Harrison","year":"2020","unstructured":"Harrison, C. Coronavirus puts drug repurposing on the fast track. Nat. Biotechnol. 38, 379\u2013381. https:\/\/doi.org\/10.1038\/d41587-020-00003-1 (2020).","journal-title":"Nat. Biotechnol."},{"key":"86016_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2020.0757","volume":"323","author":"CI Paules","year":"2020","unstructured":"Paules, C. I., Marston, H. D. & Fauci, A. S. Coronavirus infections\u2014more than just the Common Cold. JAMA 323, 707. https:\/\/doi.org\/10.1001\/jama.2020.0757 (2020).","journal-title":"JAMA"},{"key":"86016_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/088282403771926292","volume":"16","author":"S Navas-Martin","year":"2003","unstructured":"Navas-Martin, S., Weiss, S. R. & SARS Lessons learned from other coronaviruses. Viral Immunol. 16, 461\u2013474. https:\/\/doi.org\/10.1089\/088282403771926292 (2003).","journal-title":"Viral Immunol."},{"key":"86016_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1006\/viro.2000.0757","volume":"279","author":"TM Gallagher","year":"2001","unstructured":"Gallagher, T. M. & Buchmeier, M. J. Coronavirus Spike Proteins in viral entry and Pathogenesis. Virology 279, 371\u2013374. https:\/\/doi.org\/10.1006\/viro.2000.0757 (2001).","journal-title":"Virology"},{"key":"86016_CR12","doi-asserted-by":"publisher","first-page":"117808","DOI":"10.1016\/j.lfs.2020.117808","volume":"254","author":"VM Mart\u00edn Gim\u00e9nez","year":"2020","unstructured":"Mart\u00edn Gim\u00e9nez, V. M. et al. Lungs as target of COVID-19 infection: protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 254, 117808. https:\/\/doi.org\/10.1016\/j.lfs.2020.117808 (2020).","journal-title":"Life Sci."},{"key":"86016_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","volume":"203","author":"I Hamming","year":"2004","unstructured":"Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS Coronavirus. A first step in understanding SARS Pathogenesis. J. Pathol. 203, 631\u2013637. https:\/\/doi.org\/10.1002\/path.1570 (2004).","journal-title":"J. Pathol."},{"key":"86016_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s002620000109","volume":"49","author":"Y Ke","year":"2000","unstructured":"Ke, Y. et al. Noscapine inhibits Tumor Growth with little toxicity to normal tissues or inhibition of Immune responses. Cancer Immunol. Immunother. 49, 217\u2013225. https:\/\/doi.org\/10.1007\/s002620000109 (2000).","journal-title":"Cancer Immunol. Immunother"},{"key":"86016_CR15","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/med.21357","volume":"35","author":"PCG Rida","year":"2015","unstructured":"Rida, P. C. G., LiVecche, D., Ogden, A., Zhou, J. & Aneja, R. The Noscapine Chronicle: a Pharmaco-historic biography of the Opiate Alkaloid Family and its clinical applications. Med. Res. Rev. 35, 1072\u20131096. https:\/\/doi.org\/10.1002\/med.21357 (2015).","journal-title":"Med. Res. Rev."},{"key":"86016_CR16","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.2174\/1568026619666181129125524","volume":"18","author":"A Singh","year":"2019","unstructured":"Singh, A. et al. Designing of a Novel Indoline Scaffold Based Antibacterial compound and pharmacological evaluation using Chemoinformatics Approach. Curr. Top. Med. Chem. 18, 2056\u20132065. https:\/\/doi.org\/10.2174\/1568026619666181129125524 (2019).","journal-title":"Curr. Top. Med. Chem."},{"key":"86016_CR17","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.1021\/acs.jproteome.0c00367","volume":"19","author":"N Kumar","year":"2020","unstructured":"Kumar, N., Sood, D., Van Der Spek, P. J., Sharma, H. S. & Chandra, R. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for repurposing against SARS-CoV-2 protease. J. Proteome Res. 19, 4678\u20134689. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00367 (2020).","journal-title":"J. Proteome Res."},{"key":"86016_CR18","doi-asserted-by":"publisher","unstructured":"Hoque, I., Chatterjee, A., Bhattacharya, S. & Biswas, R. An Approach of Computer-Aided Drug Design (CADD) Tools for In Silico Pharmaceutical Drug Design and Development. (2017). https:\/\/doi.org\/10.22192\/ijarbs.2017.04.02.009","DOI":"10.22192\/ijarbs.2017.04.02.009"},{"key":"86016_CR19","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.3390\/molecules27072281","volume":"27","author":"YM Suleimen","year":"2022","unstructured":"Suleimen, Y. M. et al. Isolation and in Silico SARS-CoV-2 main protease inhibition potential of Jusan Coumarin, a New Dicoumarin from Artemisia Glauca. Molecules 27, 2281. https:\/\/doi.org\/10.3390\/molecules27072281 (2022).","journal-title":"Molecules"},{"key":"86016_CR20","first-page":"1000","volume":"10550","author":"R Huey","year":"2012","unstructured":"Huey, R., Morris, G. M. & Forli, S. Using AutoDock 4 and AutoDock Vina with AutoDockTools: a Tutorial. Scripps Res. Inst. Mol. Graph Lab. 10550, 1000 (2012).","journal-title":"Scripps Res. Inst. Mol. Graph Lab."},{"key":"86016_CR21","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1021\/jp0037549","volume":"105","author":"UD Priyakumar","year":"2001","unstructured":"Priyakumar, U. D. & Sastry, G. N. First Ab Initio and Density Functional Study on the Structure, Bowl-to-Bowl Inversion Barrier, and Vibrational Spectra of the Elusive C3v -Symmetric Buckybowl: Sumanene, C21 H12. J. Phys. Chem. A. 105, 4488\u20134494. https:\/\/doi.org\/10.1021\/jp0037549 (2001).","journal-title":"J. Phys. Chem. A"},{"key":"86016_CR22","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1063\/1.462066","volume":"96","author":"AD Becke","year":"1992","unstructured":"Becke, A. D. & Density-Functional Thermochemistry I. The Effect of the Exchange-only gradient correction. J. Chem. Phys. 96, 2155\u20132160. https:\/\/doi.org\/10.1063\/1.462066 (1992).","journal-title":"J. Chem. Phys."},{"key":"86016_CR23","doi-asserted-by":"crossref","unstructured":"Ghitti, M., Musco, G. & Spitaleri, A. NMR and computational methods in the structural and dynamic characterization of ligand-receptor interactions. Protein Conformational Dynamics, 271\u2013304. (2014).","DOI":"10.1007\/978-3-319-02970-2_12"},{"issue":"6","key":"86016_CR24","doi-asserted-by":"publisher","first-page":"e0302390","DOI":"10.1371\/journal.pone.0302390","volume":"19","author":"SC Ja\u2019afaru","year":"2024","unstructured":"Ja\u2019afaru, S. C. et al. Unveiling potent inhibitors for schistosomiasis through ligand-based drug design, molecular docking, molecular dynamics simulations and pharmacokinetics predictions. Plos One. 19 (6), e0302390 (2024).","journal-title":"Plos One"},{"issue":"17","key":"86016_CR25","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1021\/jm049050v","volume":"48","author":"Khandelwal","year":"2005","unstructured":"Khandelwal et al. A combination of docking, QM\/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands. J. Med. Chem. 48 (17), 5437\u20135447 (2005).","journal-title":"J. Med. Chem."},{"key":"86016_CR26","unstructured":"J.F.; m. Fattouche, M. Multi-combined Drug-likeness, 3D-QSAR Modeling, Molecular docking and Molecular Dynamics Analysis of several series of pharmaceutical (Doctoral dissertation, Universit\u00e9 Mohamed Khider (Biskra-Alg\u00e9rie)). (2024)."},{"key":"86016_CR27","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1080\/07391102.2022.2050301","volume":"41","author":"MK Da Silva","year":"2023","unstructured":"Da Silva, M. K. et al. N. computational vaccinology guided design of Multi-epitope Subunit vaccine against a neglected Arbovirus of the Americas. J. Biomol. Struct. Dyn. 41, 3321\u20133338. https:\/\/doi.org\/10.1080\/07391102.2022.2050301 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"86016_CR28","doi-asserted-by":"publisher","unstructured":"Bugnon, M. et al. Major enhancements for small-molecule docking with Attracting Cavities and AutoDock Vina: SwissDock 2024. Nuclei. Acid. Res. 52, W324\u2013W332. https:\/\/doi.org\/10.1093\/nar\/gkae300 (2024).","DOI":"10.1093\/nar\/gkae300"},{"key":"86016_CR29","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1021\/jp973084f","volume":"102","author":"A. D. Jr. Mackerell","year":"1998","unstructured":"Mackerell, A. D. Jr. et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B. 102, 3586\u20133616. https:\/\/doi.org\/10.1021\/jp973084f (1998)","journal-title":"J. Phys. Chem. B"},{"key":"86016_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/1074-5521(95)90050-0","volume":"2","author":"DK Gehlhaar","year":"1995","unstructured":"Gehlhaar, D. K. et al. Molecular Recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally Flexible Docking by Evolutionary Programming. Chem. Biol. 2, 317\u2013324. https:\/\/doi.org\/10.1016\/1074-5521(95)90050-0 (1995).","journal-title":"Chem. Biol."},{"key":"86016_CR31","unstructured":"Rational Drug Design: Novel Methodology and Practical Applications; Parrill, A.L., Reddy, M.R., Eds.; ACS Symposium Series; American Chemical Society, ; Vol. 719; ISBN 978-0-8412-3603-5. (1999)."},{"key":"86016_CR32","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"R. B. Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273. https:\/\/doi.org\/10.1021\/ct300400x (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"86016_CR33","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V. Zoete","year":"2011","unstructured":"Zoete, V. et al. SwissParam: a fast force field generation tool for small organic molecules. J. Comput. Chem. 32, 2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816 (2011).","journal-title":"J. Comput. Chem."},{"key":"86016_CR34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373. https:\/\/doi.org\/10.1038\/nmeth.4067 (2017).","journal-title":"Nat. Methods"},{"key":"86016_CR35","doi-asserted-by":"publisher","unstructured":"Wu, Z. M. et al. In Vitro Antiviral Efficacy of Caffeic Acid against Canine Distemper Virus. Microb. Pathog. 110, 240\u2013244. https:\/\/doi.org\/10.1016\/j.micpath.2017.07.006 (2017).","DOI":"10.1016\/j.micpath.2017.07.006"},{"key":"86016_CR36","doi-asserted-by":"publisher","unstructured":"Abraham, M. J. et al. High Performance Molecular Simulations through Multi-Level Parallelism from Laptops to Supercomputers. SoftwareX 1\u20132, 19\u201325, (2015). https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"86016_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel Open Source Molecular Simulation Toolkit. Bioinformatics 29, 845\u2013854. https:\/\/doi.org\/10.1093\/bioinformatics\/btt055 (2013).","journal-title":"Bioinformatics"},{"key":"86016_CR38","doi-asserted-by":"publisher","unstructured":"Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field: Improved protein side-chain potentials. Proteins Struct. Funct. Bioinforma. 78, 1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711 (2010).","DOI":"10.1002\/prot.22711"},{"key":"86016_CR39","doi-asserted-by":"crossref","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C., Fraaije, J. G. E. M. & LINCS A Linear constraint Solver for Molecular simulations. J. Comput. Chem. 18, 1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H (1997).","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L"},{"key":"86016_CR40","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/jcc.540130805","volume":"13","author":"S Miyamoto","year":"1992","unstructured":"Miyamoto, S., Kollman, P. A. & Settle An Analytical Version of the SHAKE and RATTLE algorithm for rigid water models. J. Comput. Chem. 13, 952\u2013962. https:\/\/doi.org\/10.1002\/jcc.540130805 (1992).","journal-title":"J. Comput. Chem."},{"key":"86016_CR41","doi-asserted-by":"publisher","unstructured":"Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126 https:\/\/doi.org\/10.1063\/1.2408420 (2007).","DOI":"10.1063\/1.2408420"},{"key":"86016_CR42","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/wcms.90","volume":"2","author":"J Hutter","year":"2011","unstructured":"Hutter, J. & Car-Parrinello, M. Dynamics Wiley Interdiscip Rev. Comput. Mol. Sci. 2, 604\u2013612, doi:https:\/\/doi.org\/10.1002\/wcms.90. (2011).","journal-title":"Dynamics Wiley Interdiscip Rev. Comput. Mol. Sci."},{"key":"86016_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0021-9991(74)90010-2","volume":"14","author":"RW Hockney","year":"1974","unstructured":"Hockney, R. W., Goel, S. P. & Eastwood, J. W. Quiet high-resolution computer models of a plasma. J. Comput. Phys. 14, 148\u2013158. https:\/\/doi.org\/10.1016\/0021-9991(74)90010-2 (1974).","journal-title":"J. Comput. Phys."},{"key":"86016_CR44","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","volume":"17","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco, M. S., Vald\u00e9s-Tresanco, M. E., Valiente, P. A., Moreno, E. & gmx_MMPBSA A New Tool to perform end-state Free Energy calculations with GROMACS. J. Chem. Theory Comput. 17, 6281\u20136291. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645 (2021).","journal-title":"J. Chem. Theory Comput."},{"issue":"2","key":"86016_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/138920006775541552","volume":"7","author":"SS Singh","year":"2006","unstructured":"Singh, S. S. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr. Drug Metab. 7 (2), 165\u2013182 (2006).","journal-title":"Curr. Drug Metab."},{"key":"86016_CR46","doi-asserted-by":"crossref","unstructured":"Zhou, J., Jiang, X., He, S., Jiang, H., Feng, F., Liu, W., \u2026 Sun, H. (2019). Rational design of multitarget-directed ligands: strategies and emerging paradigms. Journal of medicinal chemistry, 62(20), 8881\u20138914.","DOI":"10.1021\/acs.jmedchem.9b00017"},{"key":"86016_CR47","doi-asserted-by":"publisher","unstructured":"Morais, G. C. D. F. et al. Toxicological Potential of the FDA-Approved Treatment against Monkeypox. Comment on Zovi. Pharmacological Agents with Antiviral Activity against Monkeypox Infection. Int. J. Mol. Sci. 23, 15941. Int. J. Transl. Med. 2023, 3, 183\u2013186, (2022). https:\/\/doi.org\/10.3390\/ijtm3020013","DOI":"10.3390\/ijtm3020013"},{"key":"86016_CR48","doi-asserted-by":"publisher","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings 1PII of Original Article: S0169-409X(96)00423-1. The Article Was Originally Published in Advanced Drug Delivery Reviews 23 3\u201325. 1. Adv. Drug Deliv. Rev. 2001, 46, 3\u201326, (1997). https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"86016_CR49","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nrd2445","volume":"6","author":"PD Leeson","year":"2007","unstructured":"Leeson, P. D. & Springthorpe, B. The influence of drug-like concepts on decision-making in Medicinal Chemistry. Nat. Rev. Drug Discov. 6, 881\u2013890. https:\/\/doi.org\/10.1038\/nrd2445 (2007).","journal-title":"Nat. Rev. Drug Discov"},{"key":"86016_CR50","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n (2002).","journal-title":"J. Med. Chem."},{"key":"86016_CR51","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1021\/jm901241e","volume":"52","author":"F Lovering","year":"2009","unstructured":"Lovering, F., Bikker, J. & Humblet, C. Escape from Flatland: increasing saturation as an Approach to improving clinical success. J. Med. Chem. 52, 6752\u20136756. https:\/\/doi.org\/10.1021\/jm901241e (2009).","journal-title":"J. Med. Chem."},{"key":"86016_CR52","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","volume":"4","author":"GR Bickerton","year":"2012","unstructured":"Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S. & Hopkins, A. L. Quantifying the Chemical Beauty of drugs. Nat. Chem. 4, 90\u201398. https:\/\/doi.org\/10.1038\/nchem.1243 (2012).","journal-title":"Nat. Chem."},{"key":"86016_CR53","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s40262-020-00867-1","volume":"59","author":"M Elmeliegy","year":"2020","unstructured":"Elmeliegy, M., Vourvahis, M., Guo, C. & Wang, D. D. Effect of P-Glycoprotein (P-Gp) inducers on exposure of P-Gp substrates: review of clinical drug\u2013drug Interaction studies. Clin. Pharmacokinet. 59, 699\u2013714. https:\/\/doi.org\/10.1007\/s40262-020-00867-1 (2020).","journal-title":"Clin. Pharmacokinet."},{"key":"86016_CR54","doi-asserted-by":"publisher","first-page":"576559","DOI":"10.3389\/fonc.2020.576559","volume":"10","author":"APG Seelig","year":"2020","unstructured":"Seelig, A. P. G. One mechanism, many tasks and the consequences for Pharmacotherapy of cancers. Front. Oncol. 10, 576559. https:\/\/doi.org\/10.3389\/fonc.2020.576559 (2020).","journal-title":"Front. Oncol."},{"key":"86016_CR55","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/dmd.113.056176","volume":"42","author":"R Callaghan","year":"2014","unstructured":"Callaghan, R., Luk, F. & Bebawy, M. Inhibition of the Multidrug Resistance P-Glycoprotein: time for a change of strategy? Drug Metab. Dispos. 42, 623\u2013631. https:\/\/doi.org\/10.1124\/dmd.113.056176 (2014).","journal-title":"Drug Metab. Dispos."},{"key":"86016_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fphar.2020.00505","volume":"11","author":"ZQY Yuan","year":"2020","unstructured":"Yuan, Z. Q. Y. et al. The impact of plasma protein binding characteristics and unbound concentration of Voriconazole on its adverse drug reactions. Front. Pharmacol. 11, 505. https:\/\/doi.org\/10.3389\/fphar.2020.00505 (2020).","journal-title":"Front. Pharmacol."},{"key":"86016_CR57","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1093\/bioinformatics\/btaa075","volume":"36","author":"JY Ryu","year":"2020","unstructured":"Ryu, J. Y., Lee, M. Y., Lee, J. H., Lee, B. H. & Oh, K. S. DeepHIT: a Deep Learning Framework for Prediction of hERG-Induced Cardiotoxicity. Bioinformatics 36, 3049\u20133055. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa075 (2020).","journal-title":"Bioinformatics"},{"key":"86016_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1574886314666191004092520","volume":"15","author":"NS Craveiro","year":"2020","unstructured":"Craveiro, N. S., Lopes, B. S., Tom\u00e1s, L. & Almeida, S. F. Drug Withdrawal due to safety: a review of the data supporting Withdrawal decision. Curr. Drug Saf. 15, 4\u201312. https:\/\/doi.org\/10.2174\/1574886314666191004092520 (2020).","journal-title":"Curr. Drug Saf."},{"key":"86016_CR59","doi-asserted-by":"publisher","first-page":"e1001407","DOI":"10.1371\/journal.pmed.1001407","volume":"10","author":"RG Duijnhoven","year":"2013","unstructured":"Duijnhoven, R. G. et al. Number of patients studied prior to approval of New Medicines: a database analysis. PLoS Med. 10, e1001407. https:\/\/doi.org\/10.1371\/journal.pmed.1001407 (2013).","journal-title":"PLoS Med."},{"key":"86016_CR60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1021\/tx900326k","volume":"23","author":"D Fourches","year":"2010","unstructured":"Fourches, D. et al. Cheminformatics Analysis of Assertions Mined from literature that describe Drug-Induced Liver Injury in different species. Chem. Res. Toxicol. 23, 171\u2013183. https:\/\/doi.org\/10.1021\/tx900326k (2010).","journal-title":"Chem. Res. Toxicol."},{"key":"86016_CR61","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/biom11040607","volume":"11","author":"A Citarella","year":"2021","unstructured":"Citarella, A., Scala, A., Piperno, A. & Micale, N. SARS-CoV-2 Mpro: a potential target for peptidomimetics and small-molecule inhibitors. Biomolecules 11, 607. https:\/\/doi.org\/10.3390\/biom11040607 (2021).","journal-title":"Biomolecules"},{"key":"86016_CR62","doi-asserted-by":"publisher","unstructured":"Stille, J. K. et al. Design, synthesis and in Vitro evaluation of Novel SARS-CoV-2 3CLpro covalent inhibitors. Eur. J. Med. Chem. 229 https:\/\/doi.org\/10.1016\/j.ejmech.2021.114046 (2022).","DOI":"10.1016\/j.ejmech.2021.114046"},{"key":"86016_CR63","doi-asserted-by":"publisher","first-page":"133706","DOI":"10.1016\/j.ijbiomac.2024.133706","volume":"276","author":"H Jiang","year":"2024","unstructured":"Jiang, H., Li, W., Zhou, X., Zhang, J. & Li, J. Crystal Structures of Coronaviral Main Proteases in Complex with the non-covalent inhibitor X77. Int. J. Biol. Macromol. 276, 133706. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.133706 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"86016_CR64","doi-asserted-by":"publisher","first-page":"26748","DOI":"10.1039\/D4CP02895C","volume":"26","author":"GVR Silva","year":"2024","unstructured":"Silva, G. V. R. et al. Quantum Mechanical Analysis of newly synthesized HIV-1 protease inhibitors: evaluation of wild-type and resistant strain binding interactions. Phys. Chem. Chem. Phys. 26, 26748\u201326764. https:\/\/doi.org\/10.1039\/D4CP02895C (2024).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"86016_CR65","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1529\/biophysj.107.112045","volume":"94","author":"M And\u00e9r","year":"2008","unstructured":"And\u00e9r, M., Luzhkov, V. B. & \u00c5qvist, J. Ligand Binding to the voltage-gated Kv1.5 Potassium Channel in the Open State\u2014Docking and Computer simulations of a homology model. Biophys. J. 94, 820\u2013831. https:\/\/doi.org\/10.1529\/biophysj.107.112045 (2008).","journal-title":"Biophys. J."},{"key":"86016_CR66","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1006\/jmbi.2001.4551","volume":"308","author":"H Clau\u00dfen","year":"2001","unstructured":"Clau\u00dfen, H., Buning, C., Rarey, M. & Lengauer, T. F. E. Efficient Molecular Docking considering protein structure variations. J. Mol. Biol. 308, 377\u2013395. https:\/\/doi.org\/10.1006\/jmbi.2001.4551 (2001).","journal-title":"J. Mol. Biol."},{"key":"86016_CR67","doi-asserted-by":"publisher","first-page":"879875","DOI":"10.3389\/fmolb.2022.879875","volume":"9","author":"K Shinwari","year":"2022","unstructured":"Shinwari, K. et al. Novel Disease-Associated missense single-nucleotide polymorphisms variants Predication by Algorithms Tools and Molecular Dynamics Simulation of Human TCIRG1 Gene Causing Congenital Neutropenia and Osteopetrosis. Front. Mol. Biosci. 9, 879875. https:\/\/doi.org\/10.3389\/fmolb.2022.879875 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"86016_CR68","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3390\/vaccines11010131","volume":"11","author":"HM Rehman","year":"2023","unstructured":"Rehman, H. M. et al. Identification of NS2B-NS3 protease inhibitors for therapeutic application in ZIKV infection: a pharmacophore-based high-throughput virtual screening and MD simulations approaches. Vaccines 11, 131. https:\/\/doi.org\/10.3390\/vaccines11010131 (2023).","journal-title":"Vaccines"},{"key":"86016_CR69","doi-asserted-by":"publisher","first-page":"109347","DOI":"10.1016\/j.compbiomed.2024.109347","volume":"184","author":"M Kaur","year":"2025","unstructured":"Kaur, M. et al. Comprehensive Analysis and outcomes of hybridization of physiologically active heterocycles targeting epidermal growth factor receptor (EGFR). Comput. Biol. Med. 184, 109347. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.109347 (2025).","journal-title":"Comput. Biol. Med."},{"key":"86016_CR70","doi-asserted-by":"publisher","unstructured":"Khan, M. F. et al. Exploring optimal drug targets through Subtractive Proteomics Analysis and pangenomic insights for tailored Drug Design in Tuberculosis. Sci. Rep. 14 https:\/\/doi.org\/10.1038\/s41598-024-61752-6 (2024).","DOI":"10.1038\/s41598-024-61752-6"},{"key":"86016_CR71","doi-asserted-by":"publisher","unstructured":"Berkane, A. et al. Quercetin derivatives as potential inhibitors of Nipah Virus Phosphoprotein through in Silico Drug Design approaches. J. Indian Chem. Soc. 101 https:\/\/doi.org\/10.1016\/j.jics.2024.101196 (2024).","DOI":"10.1016\/j.jics.2024.101196"},{"issue":"9","key":"86016_CR72","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/biology9090296","volume":"9","author":"HM Rehman","year":"2020","unstructured":"Rehman, H. M. et al. A putative prophylactic solution for COVID-19: development of Novel Multiepitope Vaccine candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach. Biology (Basel). 9 (9), 296. https:\/\/doi.org\/10.3390\/biology9090296 (2020).","journal-title":"Biology (Basel)"},{"key":"86016_CR73","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1557\/s43580-023-00590-6","volume":"8","author":"R Morad","year":"2023","unstructured":"Morad, R., Akbari, M. & Maaza, M. Theoretical study of Chemical reactivity descriptors of some repurposed drugs for COVID-19. MRS Adv. 8, 656\u2013660. https:\/\/doi.org\/10.1557\/s43580-023-00590-6 (2023).","journal-title":"MRS Adv."},{"key":"86016_CR74","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/molecules29051144","volume":"29","author":"A Salamat","year":"2024","unstructured":"Salamat, A. et al. Molecular Docking and Molecular Dynamic Simulation of Natural inhibitors against SARS-CoV-2 Mpro Spike Protein. Molecules 29, 1144. https:\/\/doi.org\/10.3390\/molecules29051144 (2024).","journal-title":"Molecules"},{"key":"86016_CR75","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s11224-022-02089-6","volume":"34","author":"M Parmar","year":"2023","unstructured":"Parmar, M. et al. Structural differences in 3\u00a0C-like protease (Mpro) from SARS-CoV and SARS-CoV-2: Molecular insights revealed by Molecular Dynamics simulations. Struct. Chem. 34, 1309\u20131326. https:\/\/doi.org\/10.1007\/s11224-022-02089-6 (2023).","journal-title":"Struct. Chem."},{"key":"86016_CR76","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12033-022-00612-y","volume":"65","author":"R Gul","year":"2023","unstructured":"Gul, R. et al. Molecular Cloning, expression, sequence characterization and structural insight of Bubalus Bubalis Growth hormone-receptor. Mol. Biotechnol. 65, 1062\u20131075. https:\/\/doi.org\/10.1007\/s12033-022-00612-y (2023).","journal-title":"Mol. Biotechnol."},{"key":"86016_CR77","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/biology9090296","volume":"9","author":"HM Rehman","year":"2020","unstructured":"Rehman, H. M. et al. A putative prophylactic solution for COVID-19: development of Novel Multiepitope Vaccine candidate against SARS-COV-2 by Comprehensive Immunoinformatic and Molecular Modelling Approach. Biology 9, 296. https:\/\/doi.org\/10.3390\/biology9090296 (2020).","journal-title":"Biology"},{"key":"86016_CR78","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1039\/D1CP04361G","volume":"24","author":"S Liang","year":"2022","unstructured":"Liang, S. et al. Binding mechanism of inhibitors to SARS-CoV-2 main protease deciphered by multiple replica Molecular Dynamics simulations. Phys. Chem. Chem. Phys. 24, 1743\u20131759. https:\/\/doi.org\/10.1039\/D1CP04361G (2022).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"86016_CR79","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.str.2020.10.007","volume":"28","author":"DW Kneller","year":"2020","unstructured":"Kneller, D. W. et al. Malleability of the SARS-CoV-2 3CL Mpro active-site cavity facilitates binding of clinical antivirals. Structure 28, 1313\u20131320e3. https:\/\/doi.org\/10.1016\/j.str.2020.10.007 (2020).","journal-title":"Structure"},{"key":"86016_CR80","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","volume":"11","author":"A Douangamath","year":"2020","unstructured":"Douangamath, A. et al. Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease. Nat. Commun. 11, 5047. https:\/\/doi.org\/10.1038\/s41467-020-18709-w (2020).","journal-title":"Nat. Commun."},{"key":"86016_CR81","doi-asserted-by":"publisher","first-page":"116704","DOI":"10.1016\/j.ejmech.2024.116704","volume":"277","author":"AM Shawky","year":"2024","unstructured":"Shawky, A. M. et al. Covalent small-molecule inhibitors of SARS-CoV-2 Mpro: insights into their design, classification, Biological Activity, and binding interactions. Eur. J. Med. Chem. 277, 116704. https:\/\/doi.org\/10.1016\/j.ejmech.2024.116704 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"86016_CR82","doi-asserted-by":"publisher","unstructured":"Messore, A. et al. New Thiazolidine-4-One derivatives as SARS-CoV-2 main protease inhibitors. Pharmaceuticals 17 https:\/\/doi.org\/10.3390\/ph17050650 (2024).","DOI":"10.3390\/ph17050650"},{"key":"86016_CR83","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of Improved \u03b1-Ketoamide inhibitors. Science 368, 409\u2013412. https:\/\/doi.org\/10.1126\/science.abb3405 (2020).","journal-title":"Science"},{"key":"86016_CR84","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/life12010054","volume":"12","author":"J Byun","year":"2021","unstructured":"Byun, J. & Lee, J. Identifying the hot spot residues of the SARS-CoV-2 main protease using MM-PBSA and multiple Force Fields. Life 12, 54. https:\/\/doi.org\/10.3390\/life12010054 (2021).","journal-title":"Life"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86016-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86016-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T14:47:34Z","timestamp":1737557254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-86016-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,22]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["86016"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-86016-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,22]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2830"}}